These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6176334)

  • 1. The increased natural killer sensitivity of Epstein-Barr virus (EBV)-superinfected Raji cells is not due to the recognition of serologically determined EBV antigens by the effectors.
    Patarroyo M; Klein E; Klein G
    Cell Immunol; 1982 Feb; 67(1):152-9. PubMed ID: 6176334
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity.
    Khyatti M; Patel PC; Stefanescu I; Menezes J
    J Virol; 1991 Feb; 65(2):996-1001. PubMed ID: 1846213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma.
    Pearson GR; Qualtiere LF; Klein G; Norin T; Bal IS
    Int J Cancer; 1979 Oct; 24(4):402-6. PubMed ID: 93578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of delayed hypersensitivity reactions to lymphoid cell lines and antibodies to Epstein-Barr virus.
    Levine PH; Ho JH; Nkrumah F; Andrese AP
    IARC Sci Publ (1971); 1978; (24 Pt 2):893-8. PubMed ID: 221411
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.
    Jondal M; Gunven P
    Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients.
    Ablashi DV; De-Thé GB; Easton JM; Liabeuf A; Levine PH; Armstrong GR
    Biomedicine; 1974 Jul; 21(7):288-93. PubMed ID: 4139981
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.
    Yajima Y; Nonoyama M
    J Virol; 1976 Jul; 19(1):187-94. PubMed ID: 181594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens.
    Pearson GR; Orr TW
    J Natl Cancer Inst; 1976 Mar; 56(3):485-8. PubMed ID: 176393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent cell-mediated cytotoxicity against Epstein-Barr virus membrane antigen in African Burkitt's lymphoma.
    Granlund DJ; Nkrumah F; Perkins IV; Biggar RJ; Levine PH; Fuccillo DA
    Int J Cancer; 1979 Nov; 24(5):567-71. PubMed ID: 231015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
    Pearson G; Dewey F; Klein G; Henle G; Henle W
    J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of an Epstein-Barr virus early antigen and cell fusion].
    Furukawa M; Kamide M; Kato C; Sakashita H; Takeshita H; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 May; 92(5):722-5. PubMed ID: 2559176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines.
    Takada K
    Int J Cancer; 1984 Jan; 33(1):27-32. PubMed ID: 6319296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface markers on epithelial-Burkitt hybrid cells superinfected with Epstein-Barr virus.
    Glaser R; Lenoir G; Ferrone S; Pellegrino MA; de-Thé G
    Cancer Res; 1977 Jul; 37(7 Pt 1):2291-6. PubMed ID: 193641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.
    Khyatti M; Stefanescu I; Blagdon M; Menezes J
    J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.
    Qualtiere LF; Pearson GR
    Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p105, an Epstein-Barr virus-induced, phosphonoacetic acid-insensitive glycoprotein target of the anti-Epstein-Barr virus immune response.
    Casareale D; Jones W; Sairenji T; Humphreys RE
    Infect Immun; 1983 Jan; 39(1):85-90. PubMed ID: 6295961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.
    Klein G; Dombos L; Gothoskar B
    Int J Cancer; 1972 Jul; 10(1):44-57. PubMed ID: 4122458
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in antibodies to Epstein-Barr virus-associated antigens with the development of Burkitt's lymphoma.
    Magrath IT; Henle W
    IARC Sci Publ (1971); 1975; (11 Pt 2):275-81. PubMed ID: 191371
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.
    Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE
    J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.